Global Aesthetic Medicine and Cosmetic Surgery Market Size By Type (Invasive Procedures, Non-surgical Procedure), By Application (Hospitals, Dermatology clinics), By Region, And Segment Forecasts, 202...

The Global Aesthetic Medicine and Cosmetic Surgery Market was valued at USD 73.4 billion in 2023 and is projected to reach USD 149.3 billion by 2031, expanding at a CAGR of 9.2% from 2023 to 2031. This growth is driven by rising demand for non-invasive and minimally invasive aesthetic procedures, increased awareness of cosmetic enhancements, and technological advancements in treatment modalities. A growing aging population, social media influence, and increased disposable income are accelerating global interest in aesthetic treatments, especially across Asia-Pacific and Latin America.

Drivers:

1. Rising Demand for Non-Invasive Procedures:

Technologies like botulinum toxin injections, dermal fillers, laser skin resurfacing, and body contouring are gaining popularity due to minimal downtime and low risk. Patients prefer these treatments for quicker recovery and natural-looking results.

2. Increasing Aesthetic Awareness:

Consumers are more educated about aesthetic treatments, driven by media exposure and influencer culture. This awareness is translating into greater acceptance and demand across all age groups.

3. Technological Innovation:

Laser-based devices, cryolipolysis, RF microneedling, ultrasound therapy, and AI-enhanced diagnostics have improved the efficacy and safety of both surgical and non-surgical procedures.

Restraints:

1. High Treatment Costs:

Cosmetic surgeries and advanced skin treatments remain expensive, especially in developed countries, limiting access to a broader customer base.

2. Regulatory and Ethical Challenges:

Inconsistent regulations across countries and ethical concerns regarding overuse of aesthetic treatments could hinder market expansion.

Opportunity:

1. Growth in Emerging Markets:

Countries such as Brazil, India, Mexico, and China are witnessing a surge in cosmetic procedures, supported by economic growth, medical tourism, and increasing middle-class affordability.

2. Male Aesthetic Market Growth:

An increasing number of men are opting for aesthetic procedures like botox, liposuction, and hair restoration, creating a new and untapped demographic opportunity.

Market by System Type Insights:

The Non-Surgical Aesthetic Procedures segment dominated the market in 2023, accounting for over 60% of the global revenue. Treatments such as injectables (botox and fillers), laser hair removal, and chemical peels are in high demand due to their lower cost and shorter recovery time. Meanwhile, the Surgical Procedures segment—comprising rhinoplasty, liposuction, and breast augmentation—is also growing steadily due to increasing acceptance and improved surgical outcomes.

Market by End-use Insights:

In 2023, Medspa & Dermatology Clinics emerged as the largest revenue contributor, attributed to high procedure volumes, affordability, and experienced professionals. Hospitals & Cosmetic Surgery Centers are projected to grow rapidly, especially in countries with advanced healthcare infrastructure, offering more complex surgical procedures.

Market by Regional Insights:

North America dominated the market in 2023, led by the U.S., with high disposable incomes and a mature medical aesthetics industry. Asia-Pacific is expected to register the fastest growth, fueled by expanding medical tourism, increasing acceptance of cosmetic procedures, and rising middle-class populations in India, China, and South Korea. Europe also remains a significant contributor, driven by rising demand in countries like Germany, France, and Italy.

Competitive Scenario:

Key players in the global aesthetic medicine and cosmetic surgery market include AbbVie Inc. (Allergan), Ipsen, Evolus, Alma Lasers, Cynosure, Galderma, Lumenis, Cutera Inc., Syneron Candela, and Johnson & Johnson. These companies are focusing on continuous product innovation, mergers & acquisitions, and strategic partnerships.

Recent Developments:

In 2023, Galderma launched its next-gen hyaluronic acid filler with improved longevity and volume retention.

In 2024, AbbVie received FDA approval for a new botulinum toxin formulation targeting dynamic wrinkles with longer duration.

In 2025, Cynosure partnered with medispas across Southeast Asia to expand access to its non-invasive body contouring solutions.

Scope of Work – Global Aesthetic Medicine and Cosmetic Surgery Market

Key Market Developments:

2023: Galderma introduced long-lasting dermal fillers targeting midface volume loss.

2024: Allergan expanded its injectable product line in Southeast Asia.

2025: Alma Lasers unveiled a compact RF microneedling system for in-office facial rejuvenation.

FAQs:

1. What is the current market size of the Global Aesthetic Medicine and Cosmetic Surgery Market?

The market was valued at USD 73.4 billion in 2023.

2. What is the major growth driver of the Global Aesthetic Medicine and Cosmetic Surgery Market?

The major driver is the rising demand for non-invasive and minimally invasive aesthetic procedures.

3. Which is the largest region during the forecast period in the Global Aesthetic Medicine and Cosmetic Surgery Market?

North America led the market in 2023, while Asia-Pacific is expected to grow the fastest by 2031.

4. Which segment accounted for the largest market share in the Global Aesthetic Medicine and Cosmetic Surgery Market?

The Non-Surgical Procedures segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Aesthetic Medicine and Cosmetic Surgery Market?

Key players include AbbVie, Galderma, Alma Lasers, Cynosure, Evolus, and Johnson & Johnson.